Important Safety Information

What Is Tesamorelin?

Tesamorelin therapy is considered an elective wellness treatment. A different tesamorelin product is FDA-approved for a specific medical use. Belle's compounded tesamorelin is not that product and has not been evaluated by the FDA for safety or effectiveness. It is not intended to diagnose, treat, cure, or prevent any disease.

Always consult your healthcare provider before beginning any injectable regimen, especially if you have pre-existing health conditions.

Who Should Not Use Tesamorelin

Tesamorelin should not be used by individuals who:

• Are allergic to Tesamorelin or any ingredient in the formulation
• Are pregnant, trying to become pregnant, or breastfeeding
• Have an active cancer, or a history of cancer, without clearance from their oncology provider
• Have uncontrolled chronic illnesses without supervision from a licensed provider

Precautions and Warnings

Inform your provider if you have or have had:

• Diabetes or blood sugar dysregulation
• Active or past malignancy, especially pituitary or hypothalamic tumors
• Fluid retention or edema
• Carpal tunnel syndrome
• Kidney or liver disease
• Hypothyroidism

Common Side Effects

Side effects associated with Tesamorelin may include:

• Injection site redness, itching, swelling, or pain
• Joint or muscle pain
• Swelling in the hands or feet
• Numbness or tingling
• Headache
• Nausea

If you experience any severe or prolonged symptoms, notify your provider immediately.

Serious Reactions (Rare)

In rare cases, patients may experience:

• Hypersensitivity or allergic reaction
• Significant changes in blood sugar levels
• Signs of infection at the injection site (spreading redness, warmth, pus, or fever)
• Worsening of pre-existing conditions

Stop treatment and seek medical attention immediately if you experience trouble breathing, chest pain, or swelling of the face, lips, or throat.

Use and Administration

• Use Tesamorelin only as directed by your licensed provider.
• Do not exceed the prescribed dosage or frequency.
• Tesamorelin is typically administered via subcutaneous injection unless your provider directs otherwise.
• If you miss a dose, contact your provider for guidance before resuming.
• Report any adverse effects or unexpected symptoms during treatment.

Storage and Disposal

Store Tesamorelin as directed on the pharmacy label, typically refrigerated and protected from light. Do not use expired products. Dispose of needles in a sharps container. Keep out of reach of children.